Literature DB >> 25560008

Clonal evolution multi-drug resistant Acinetobacter baumannii by pulsed-field gel electrophoresis.

P Mohajeri, A Farahani1, M M Feizabadi, B Norozi.   

Abstract

BACKGROUND: Acinetobacter baumannii is usually multi-drug resistant (MDR), including third generation cephalosporins, amino glycosides and fluoroquinolone. Resistance to these antibiotics is mediated by multiple factors such as: lactamases, efflux pumps and other mechanisms of resistance. Pulsed-field gel electrophoresis (PFGE) was then used to investigate the genetic relationships among the MDR isolates. AIM: The aim of this study was to determine MDR isolates and the existence of OXAs genes among MDR isolates of A. baumannii collected from Kermanshah hospitals in west of Iran.
MATERIALS AND METHODS: Forty-two MDR A. baumannii were collected from patients at Kermanshah hospitals. The isolates were identified by biochemical tests and API 20NE kit. The susceptibility to different antibiotics by disk diffusion method was determined. Polymerase chain reaction (PCR) was performed for detection of blaOXA-23-like , blaOXA-24-like , blaOXA-51-like and blaOXA-58-like betalactamase genes in isolates and clonal relatedness was done by PFGE (with the restriction enzyme ApaI) and patterns analyzed by Bionumeric software.
RESULTS: This study showed high resistant to ciprofloxacin, piperacillin, ceftazidime and also resistant to other anti-microbial agents and more spread blaOXA-23-like gene (93%) in MDR isolate. The PFGE method obtained six clones: A (10), B (9), C (5), D (4), E (11) and F (3) that clone E was outbreak and dominant in different wards of hospitals studied.
CONCLUSION: An isolate from the emergency ward of these hospitals had indistinguishable isolates PFGE profile and similar resistance profile to isolates from intensive care unit (ICU), suggesting likely transmission from ICU to emergency via patient or hospital staff contact.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25560008     DOI: 10.4103/0255-0857.148390

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  6 in total

1.  Molecular Characterization of Multidrug Resistant Strains of Acinetobacter baumannii Isolated from Intensive Care Units in West of Iran.

Authors:  Parviz Mohajeri; Abbas Farahani; Rasa Sheini Mehrabzadeh
Journal:  J Clin Diagn Res       Date:  2017-02-01

2.  Frequency of Class 1 Integron and Genetic Diversity of Acinetobacter baumannii Isolated from Medical Centers in Kermanshah.

Authors:  Mahsa Eghbalimoghadam; Abbas Farahani; Farahtaj Navab Akbar; Parviz Mohajeri
Journal:  J Nat Sci Biol Med       Date:  2017 Jul-Dec

3.  Emergence of High Prevalence of Extended-Spectrum Beta-Lactamase and Carbapenemase Producing Acinetobacter Species and Pseudomonas aeruginosa Among Hospitalized Patients at Dessie Comprehensive Specialized Hospital, North-East Ethiopia.

Authors:  Mihret Tilahun; Alemu Gedefie; Habitye Bisetegn; Habtu Debash
Journal:  Infect Drug Resist       Date:  2022-03-08       Impact factor: 4.003

4.  Evaluate the frequency distribution of nonadhesive virulence factors in carbapenemase-producing Acinetobacter baumannii isolated from clinical samples in Kermanshah.

Authors:  Parviz Mohajeri; Saba Sharbati; Abbas Farahani; Zhaleh Rezaei
Journal:  J Nat Sci Biol Med       Date:  2016 Jan-Jun

5.  Study of genetic diversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant Acinetobacter baumannii isolated from burn wound infections in Iran.

Authors:  Reza Ranjbar; Abbas Farahani
Journal:  Antimicrob Resist Infect Control       Date:  2019-11-07       Impact factor: 4.887

6.  Molecular typing of multi-drug resistant Acinetobacter baumannii isolates from clinical and environmental specimens in three Iranian hospitals by pulsed field gel electrophoresis.

Authors:  Ali Mohammadi Bardbari; Parviz Mohajeri; Mohammad Reza Arabestani; Manoochehr Karami; Fariba Keramat; Saba Asadollahi; Amir Khodavirdipour; Mohammad Yousef Alikhani
Journal:  BMC Microbiol       Date:  2020-04-25       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.